Focal thyroid incidentalomas identified with whole-body FDG-PET warrant further investigation

Irish Medical Journal

Volumn 104, Issue 6, 2011, Pages

  Prichard, R S ^a   Cotter, M ^a   Evoy, D ^a   Gibbons, D ^a   Collins, C ^a   Mcdermott, E ^a   Skehan, S ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NODULAR GOITER; PREVALENCE; RETROSPECTIVE STUDY; THYROID GLAND EXAMINATION; THYROID INCIDENTALOMA; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; WHOLE BODY PET; INCIDENTAL FINDING; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; SCINTISCANNING; THYROID TUMOR; WHOLE BODY IMAGING;

AGED; CARCINOMA, PAPILLARY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; WHOLE BODY IMAGING;

EID: 79960573181     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Thyroid Carcinoma statistics. National Irish Cancer Registry 2006.
2. Tan GH, Gharib H. Thyroid Incidentalomas: management approaches to non-palpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126: 226-231
3. Burguera B, Gharib H. Thyroid Incidentalomas. Prevalence, diagnosis, significance and management. Endocrinology and metabolism clinics of North America 2000; 29: 187-203
4. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid Gland: US screening in a random adult population. Radiology 1991; 181: 683-687
5. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid Incidentalomas. Prevalence by palpation and ultrasonography. Arch International Medicine 1994; 154: 1838-1840
6. Strauss L, Conti PS. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-648
7. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncology 2001; 2: 157-164
8. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130: 941-946
9. Van der Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, Delaere P, Bouillon R. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002; 87: 1517-1520
10. Kang KW, Kim SK, Kang HS, Lee ES, Sim JS, Lee IG, Jeong SY, Kim SW. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88: 4100-4104
11. Kim TY, Kim WB, Ryu JS, Ging G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid incidentaloma. Laryngoscope 2005; 115: 1074-1078
12. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 2005; 236: 271-275
13. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chumg JH, Lee KH, Kim BT. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006; 47: 609-615
14. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Communications 2009; 30: 240-244
15. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, Horiuchi M. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207: 775-778
16. Wolf G, Aigner RM, Schaffler G, Schwartz T, Krippl P. Pathology results in 18F-fluorodeoxyglucose positron emission tomography of the thyroid gland. Nucl Med Communications 2003; 24: 1225-1230
17. Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985; 313: 428-436
18. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007; 48: 896-901
19. Naklyavani MK, Gharib H, Goellner JR, Van Hearden JA. Metastasis to the thyroid gland. A report of 43 cases. Cancer 1997; 79: 574-578
20. Grant CS, Hay ID, Gough IR, McCarthy PM. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytological diagnosis. Surgery 1989; 106: 980-986